Saw Palmetto Side Effects: What the Big Trials Actually Found
Educational summary of published research — not medical advice. New or unexplained abdominal pain, unusual bleeding, or urinary symptoms deserve a clinician's evaluation, not self-treatment. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Saw palmetto's safety data is unusually strong for a supplement — stronger, in fact, than its efficacy data. In the STEP trial's detailed safety assessment, serious adverse events were less common with saw palmetto than with placebo (5.4% vs 9.7%, not a statistically significant difference) and non-serious adverse events were similar between groups (34.8% vs 30.1%) (Avins 2008). The CAMUS trial then escalated the dose to two and three times standard over 72 weeks and still reported no clearly attributable adverse effects (Barry 2011). That's a real tolerability finding, not just an absence of proof — "not significantly different from placebo" describes what these trials measured, not a guarantee of zero risk. Outside the trials: mild GI upset is the most-reported complaint, a handful of case reports describe rare pancreatitis and liver injury, one case report describes a bleeding episode, and the trial evidence says it does not mask a PSA test (Andriole 2013).
Looking for a tested product? See our best saw palmetto ranked by disclosed standardization and cost per day — and if you haven't already, read whether it actually works before deciding whether the tradeoff is worth it →
The trial evidence: an unusually good tolerability story
Most supplement safety claims rest on small studies or anecdote. Saw palmetto is a rare exception, because the same large, rigorous trials that failed to find a benefit for BPH also collected careful safety data — and that data holds up. The STEP trial's dedicated safety analysis followed 225 men for a full year on a standardized extract (160 mg twice daily) versus placebo, tracking serious adverse events, non-serious adverse events, sexual function, and blood and urine labs. The result: serious adverse events were numerically lower in the saw palmetto group than placebo (5.4% vs 9.7%, p=0.31 — not a significant difference, and if anything favoring saw palmetto), and non-serious adverse events were similar (34.8% vs 30.1%, p=0.48) (Avins 2008).
The CAMUS trial then did something most supplement trials never attempt: it deliberately pushed the dose higher to see if safety would hold. Over 72 weeks, 369 men were escalated from the standard 320 mg/day to 640 mg/day and finally to 960 mg/day — three times the standard dose — while a placebo group followed the same schedule. The trial's own conclusion: "No clearly attributable adverse effects were identified" (Barry 2011). That is a genuinely stronger tolerability statement than most supplements can make, because most are never dose-escalated in a placebo-controlled trial to see where problems start. The honest caveat: absence of a detected difference in a few hundred people over roughly a year and a half doesn't rule out a rare event happening in 1 in 10,000 users — the case reports below are exactly the kind of rare signal a trial this size isn't built to catch.
The common complaint: mild GI effects
When people do report something, it's usually mild gastrointestinal discomfort — an upset stomach, nausea, or an unpleasant taste, particularly on an empty stomach. This tracks with the STEP data above: non-serious adverse events (the category GI complaints would fall into) occurred at a similar rate in the saw palmetto and placebo groups, so even the "common" side effect isn't clearly attributable to the supplement rather than to chance or expectation. Taking it with meals is the standard practical fix, though we're not aware of a trial that specifically tested that adjustment for saw palmetto.
Rare but real: case reports of pancreatitis and liver injury
Outside the controlled trials, three published case reports describe men who developed acute pancreatitis while taking saw palmetto, with symptoms improving after they stopped it. The most detailed case involved a 55-year-old man who had intermittently taken saw palmetto for about four years for BPH; he developed both pancreatitis and marked liver-enzyme elevations (AST and ALT each above 1,200), and the pattern recurred twice when he restarted saw palmetto after improving off it — a rechallenge pattern that's fairly strong evidence of a drug effect in that specific patient (Jibrin 2006). Two later case reports describe isolated acute pancreatitis, without the liver involvement, that likewise resolved once saw palmetto was stopped (Wargo 2010; Bruminhent 2011).
Read this in proportion. It is three case reports, against a supplement millions of men have used, over roughly two decades of published literature — not a signal the STEP or CAMUS trials detected at their sample sizes. It is not evidence that saw palmetto commonly harms the liver or pancreas, and none of these authors claim otherwise; each describes their case as "probable" or "possible," the standard hedge for a single-patient causality call. What it does mean: if you develop new, unexplained upper-abdominal pain, nausea, or vomiting while taking saw palmetto, that's worth mentioning to a doctor and worth stopping the supplement until you know why.
A theoretical caution: bleeding
One published case report describes a patient on saw palmetto who experienced severe bleeding during surgery; his bleeding time was prolonged before the operation and returned to normal within a few days of stopping the herb (Cheema 2001). That is a single case report, not trial evidence of a bleeding effect in general use, and we're not aware of a controlled study that has since confirmed or ruled out an effect on clotting. It's consistent enough with a plausible, theoretical antiplatelet mechanism that standard perioperative guidance treats it as a reason for caution rather than dismissing it. If you take a blood thinner, have a bleeding disorder, or have surgery scheduled, tell your doctor you're taking saw palmetto and ask whether to pause it beforehand.
Does it interfere with a PSA test?
No, and this is one of the more directly answered questions here. The CAMUS trial measured PSA at baseline and again as the dose was escalated to 640 mg/day and then 960 mg/day, and found the change in PSA over the study was essentially the same in the saw palmetto and placebo groups at every dose tested (Andriole 2013). That distinction matters clinically: finasteride and other 5-alpha-reductase inhibitors do suppress PSA, which is why doctors adjust how they interpret a PSA test for men on those drugs. Saw palmetto, despite sharing a proposed (and unproven) mechanism with those drugs, doesn't share that PSA effect in trial data — so it shouldn't distort your screening results, whether or not it's doing anything for your symptoms.
Saw palmetto side effects at a glance
| Effect | What the evidence shows | How common | What to do |
|---|---|---|---|
| Overall tolerability | STEP: serious AEs lower with saw palmetto than placebo (not significant); CAMUS: no clearly attributable AEs even at 3× dose | N/A — a trial-level finding | Reassuring, but doesn't rule out rare events below |
| Mild GI upset (stomach discomfort, nausea, taste) | Most-reported complaint; not clearly above placebo rates in STEP | The most common issue, still uncommon | Take with food if it occurs |
| Pancreatitis | 3 published case reports, symptoms resolved on stopping | Rare (case-report level) | Stop and see a doctor for new upper-abdominal pain/nausea |
| Liver injury | 1 of the 3 pancreatitis case reports also showed marked liver-enzyme elevation, with positive rechallenge | Very rare (1 case report) | Same as above; mention any liver disease to your doctor |
| Bleeding | 1 case report of severe intraoperative bleeding, reversible on stopping; theoretical antiplatelet mechanism | Very rare (1 case report) | Tell your doctor before surgery or if on blood thinners |
| PSA test interference | CAMUS: no PSA effect vs. placebo, even at 3× dose | Not observed | No special precaution needed for PSA screening |
Compare Saw Palmetto Products by Disclosed Standardization and Cost Per Day
If the safety profile is what's drawing you to saw palmetto, here's how the products we track and verify compare on disclosed standardization and cost per day at the studied 320mg dose.
Frequently asked questions
Is saw palmetto safe?
The safety data is unusually good for a supplement, even though the efficacy data is not. In the STEP trial's detailed safety assessment, serious adverse events were actually less common with saw palmetto than placebo (5.4% vs 9.7%, not a statistically significant difference), and non-serious adverse events were similar between groups (34.8% vs 30.1%) (Avins 2008). The CAMUS trial then escalated the dose to two and three times standard over 72 weeks and still found no clearly attributable adverse effects. That doesn't mean zero risk — rare case reports exist for pancreatitis, liver injury, and one bleeding episode — but the large-trial signal is genuinely reassuring.
What are the most common saw palmetto side effects?
Mild gastrointestinal effects — stomach upset, nausea, or a bad taste — are what shows up most often, and even these were not reported at rates meaningfully higher than placebo in the controlled trials. Taking it with food is the standard way to reduce GI discomfort, though there isn't trial data specifically testing that fix for saw palmetto. Beyond GI upset, the trial evidence doesn't show a distinct pattern of common side effects.
Can saw palmetto hurt your liver or pancreas?
It's rare, but there are published case reports. Three case reports describe acute pancreatitis developing in men taking saw palmetto, with symptoms resolving after they stopped it (Jibrin 2006; Wargo 2010; Bruminhent 2011). One of those cases also involved a marked rise in liver enzymes alongside the pancreatitis, and resolved and recurred twice with stopping and restarting the supplement, which is fairly strong evidence of a drug effect in that individual (Jibrin 2006). This is not evidence that saw palmetto commonly damages the liver or pancreas — it's three case reports against a supplement used by millions of men, and the large controlled trials didn't detect a comparable signal. But it means new, unexplained abdominal pain while taking saw palmetto is worth telling a doctor about.
Does saw palmetto interact with blood thinners or increase bleeding risk?
There's a published case of a patient on saw palmetto who had severe bleeding during surgery, with a prolonged bleeding time that returned to normal a few days after stopping the herb (Cheema 2001). That's one case report, not trial-level evidence of a bleeding effect, but it's consistent with a theoretical concern about platelet function that shows up in reviews of the supplement. If you take a blood thinner, have a bleeding disorder, or have upcoming surgery, tell your doctor you're taking saw palmetto and ask whether to stop it beforehand.
Does saw palmetto mess with a PSA test?
No — this is one of the better-answered safety questions about it. The CAMUS trial measured PSA at baseline and at three points as the dose was escalated up to 960mg/day (three times standard), and found no meaningful difference in PSA change between the saw palmetto and placebo groups at any dose (Andriole 2013). That matters because a related drug class, 5-alpha-reductase inhibitors like finasteride, does suppress PSA and can mask early cancer signals on a screening test — saw palmetto does not share that effect, so it shouldn't distort your PSA results.
Related guides
- Saw Palmetto Benefits — what the evidence actually supports, honestly mapped
- Does Saw Palmetto Work? — the full BPH trial breakdown and the Permixon nuance
- Standardized Extract vs Berry Powder — the label trap behind most products
- Saw Palmetto Dosage Guide — the 320mg studied dose
- Best Saw Palmetto — ranked by disclosed standardization, then cost
- All Saw Palmetto Guides
Sources
- Avins AL, et al. "A detailed safety assessment of a saw palmetto extract." Complement Ther Med. 2008;16(3):147-54. PMID: 18534327
- Barry MJ, et al. "Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial." JAMA. 2011;306(12):1344-51. PMID: 21954478
- Andriole GL, et al. "The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial." J Urol. 2013;189(2):486-92. PMID: 23253958
- Jibrin I, et al. "Saw palmetto-induced pancreatitis." South Med J. 2006;99(6):611-2. PMID: 16800417
- Wargo KA, et al. "A possible case of saw palmetto-induced pancreatitis." South Med J. 2010;103(7):683-5. PMID: 20531057
- Bruminhent J, et al. "Acute pancreatitis with saw palmetto use: a case report." J Med Case Rep. 2011;5:414. PMID: 21867545
- Cheema P, et al. "Intraoperative haemorrhage associated with the use of extract of Saw Palmetto herb: a case report and review of literature." J Intern Med. 2001;250(2):167-9. PMID: 11489067